A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study
The objective of this study was to assess the effectiveness of Brivera when used as an adjunctive therapy for individuals diagnosed with epilepsy.